SynthesisFrontiers in immunology2025

Efficacy and safety of PD-1/PD-L1 and CTLA-4 immune checkpoint inhibitors in the treatment of diffuse pleural mesothelioma: a systematic review and meta-analysis.

Peiyuan Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.